Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

Articles related to DRUG SHORTAGES

Pharmacy Practice News

Nationwide Adderall Shortage May Last into 2023

Teva Pharmaceuticals is the primary supplier of both branded and generic versions of the stimulant, which is approved to treat ADHD and narcolepsy. Teva has cited increased demand, workforce shortages, and manufacturing disruptions due to packaging constraints as reasons for the supply problems.

Clinical Pharmacology October 27th 2022

Tags: ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG SHORTAGES HEALTHCARE ACCESS INSOMNIA/SLEEP DISORDERS STIMULANTS

Topics

Sources

ACP Internist
Annals of Internal Medicine
ASH Clinical News
Blood
Blood Advances
British Medical Journal (The BMJ)
Cancer Therapy Advisor
Cleveland Clinic Journal of Medicine
Clinical Advances in Hematology & Oncology
GoodRx Health
Healthgrades for Professionals
JAMA Network
Journal of Clinical Oncology
MDLinx
MedPage Today
Medical Professionals Reference (MPR)
Neurology Advisor
Psychiatrist.com
ReachMD
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form